Proactive use of plasma and platelets in massive transfusion in Trauma: The long road to acceptance and a lesson in evidence-based medicine

Anesthesia and Analgesia

Volumn 123, Issue 6, 2016, Pages 1618-1622

  Ho, Anthony M H ^a   Mizubuti, Glenio B ^a   Dion, Peter W ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b Niagara Health Services   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR;

ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL DECISION MAKING; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED MEDICINE; EXSANGUINATION; HEMATOCRIT; HUMAN; INJURY; MASSIVE TRANSFUSION PROTOCOL; MORTALITY; PLASMA TRANSFUSION; PRIORITY JOURNAL; RESUSCITATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; UNITED STATES; PLASMA; RISK FACTOR; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; EXSANGUINATION; HUMANS; PLASMA; PLATELET TRANSFUSION; RISK FACTORS; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 84996528068     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000001579     Document Type: Article

References (36)

1. Hewson JR, Neame PB, Kumar N, et al. Coagulopathy related to dilution and hypotension during massive transfusion. Crit Care Med. 1985; 13: 387-391
2. Ho AMH, Karmakar MK, Dion PW. Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg. 2005; 190: 479-484
3. Brockamp T, Nienaber U, Mutschler M, et al; TraumaRegister DGU. Predicting on-going hemorrhage and transfusion requirement after severe trauma: a validation of six scoring systems and algorithms on the TraumaRegister DGU. Crit Care. 2012; 16: R129
4. Dzik WH, Blajchman MA, Fergusson D, et al. Clinical review: Canadian National Advisory Committee on Blood and Blood Products-Massive transfusion consensus conference 2011: report of the panel. Crit Care. 2011; 15: 242
5. Johansson PI, Stensballe J, Oliveri R, Wade CE, Ostrowski SR, Holcomb JB. How I treat patients with massive hemorrhage. Blood. 2014; 124: 3052-3058
6. Ho AMH, Dion PW, Yeung JH, et al. Prevalence of survivor bias in observational studies on fresh frozen plasma: erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology. 2012; 116: 716-728
7. Ho AMH, Dion PW, Yeung JH, et al. Simulation of survivorship bias in observational studies on plasma to red blood cell ratios in massive transfusion for trauma. Br J Surg. 2012; 99 Suppl 1: 132-139
8. Snyder CW, Weinberg JA, McGwin G Jr, et al. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma. 2009; 66: 358-362
9. Young PP, Cotton BA, Goodnough LT. Massive transfusion protocols for patients with substantial hemorrhage. Transfus Med Rev. 2011; 25: 293-303
10. Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016; 20: 100
11. Glassberg E, Nadler R, Gendler S, et al. Freeze-dried plasma at the point of injury: from concept to doctrine. Shock. 2013; 40: 444-450
12. Kashuk JL, Moore EE, Johnson JL, et al. Postinjury life threatening coagulopathy: is 1: 1 fresh frozen plasma: packed red blood cells the answer? J Trauma. 2008; 65: 261-270
13. Teixeira PG, Inaba K, Shulman I, et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma. 2009; 66: 693-697
14. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B; Working Group on Polytrauma of the German Society of Trauma Surgery (DGU). Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie. Vox Sang. 2008; 95: 112-119
15. Holcomb JB, del Junco DJ, Fox EE, et al; PROMMTT Study Group. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013; 148: 127-136
16. Holcomb JB, Tilley BC, Baraniuk S, et al; PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1: 1: 1 vs a 1: 1: 2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015; 313: 471-482
17. Pham HP, Shaz BH. Update on massive transfusion. Br J Anaesth. 2013; 111 Suppl 1: i71-82
18. Riskin DJ, Tsai TC, Riskin L, et al. Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg. 2009; 209: 198-205
19. Nascimento B, Callum J, Tien H, et al. Effect of a fixed-ratio (1: 1: 1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ. 2013; 185: E583-589
20. Cotton BA, Podbielski J, Camp E, et al; Early Whole Blood Investigators. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg. 2013; 258: 527-532
21. Ho AMH, Dion PW, Cheng CA, et al. A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage. Can J Surg. 2005; 48: 470-478
22. Ho AMH, Dion PW, Yeung JH, et al. Fresh-frozen plasma transfusion strategy in trauma with massive and ongoing bleeding. Common (sense) and sensibility. Resuscitation. 2010; 81: 1079-1081
23. Ho AMH, Holcomb JB, Ng CS, Zamora JE, Karmakar MK, Dion PW. The traditional vs 1: 1: 1 approach debate on massive transfusion in trauma should not be treated as a dichotomy. Am J Emerg Med. 2015; 33: 1501-1504
24. Zielinski MD, Jenkins DH, Hughes JD, Badjie KS, Stubbs JR. Back to the future: the renaissance of whole-blood transfusions for massively hemorrhaging patients. Surgery. 2014; 155: 883-886
25. Spinella PC. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Crit Care Med. 2008; 36: S340-345
26. Tapia NM, Chang A, Norman M, et al. TEG-guided resuscitation is superior to standardized MTP resuscitation in massively transfused penetrating trauma patients. J Trauma Acute Care Surg. 2013; 74: 378-385
27. da Luz LT, Nascimento B, Rizoli S. Thrombelastography (TEG®): practical considerations on its clinical use in trauma resuscitation. Scand J Trauma Resus Emerg Med. 2013; 21: 29
28. Schöchl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasmabased therapy. Crit Care. 2011; 15: R83
29. Schöchl H, Voelckel W, Schlimp CJ. Management of traumatic haemorrhage-the European perspective. Anaesthesia. 2015; 70(suppl 1): 102-107, e35-7
30. Dutton RP. Management of traumatic haemorrhage-the US perspective. Anaesthesia. 2015; 70(suppl 1): 108-111, e38
31. Holcomb JB, Pati S. Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon's perspective. Hematology Am Soc Hematol Educ Program. 2013; 2013: 656-659
32. Murphy CH, Hess JR. Massive transfusion: red blood cell to plasma and platelet unit ratios for resuscitation of massive hemorrhage. Curr Opin Hematol. 2015; 22: 533-539
33. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ. 2003; 327: 1459-1461
34. Pedersen T, Nicholson A, Hovhannisyan K, Mller AM, Smith AF, Lewis SR. Pulse oximetry for perioperative monitoring. Cochrane Database Syst Rev. 2014; 3: CD002013
35. Every-Palmer S, Howick J. How evidence-based medicine is failing due to biased trials and selective publication. J Eval Clin Pract. 2014; 20: 908-914
36. Godlee F. Editor in chief's reply to Nguyen-Van-Tam. BMJ. 2014; 348: g2951